Tomorrow's Science For Today's Clinician
India reported 24,696 new COVID-19 incidences on Monday. With as many as 438 fatalities were recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,32,112.
Collective results from recent clinical trials indicate that an oral drug called roxadustat is an effective treatment for anemia in patients with chronic kidney disease who do not require dialysis. The results were published in an upcoming issue of CJASN.
A study led by researchers from University of Birmingham showed that an oral drug, fenofibrate and its active form fenofibric acid used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent.
The Indian Council of Medical Research said on Sunday that a combination of Covishield and Covaxin gives better protection to the human body than two doses of the same vaccine.
India reported 36,036 new COVID-19 incidences on Sunday. With as many as 447 fatalities were recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,27,401.
India reported 38,705 new COVID-19 incidences on Friday. With as many as 616 fatalities were recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,27,401.
A team of researchers from the Massachusetts Institute of Technology (MIT), is a private land-grant research university in Cambridge, has now developed an immunotherapy strategy of combining three drugs and has shown that it can eliminate pancreatic tumours in mice.
Johnson & Johnson (J&J) has sought approval for its single-shot Covid-19 vaccine from the Indian drug regulator. This will be the fourth foreign vaccine to enter India after Russia’s Sputnik V, Pfizer-BioNTech and Moderna.
More than half a billion doses of COVID-19 vaccines have been administered in South-East Asia Region, according to the World Health Organisation. The maximum– 489 million doses– have been administered in India, which reached 8.6 million people on day one of its reinvigorated campaign in June.
A study published in the Journal of Clinical Oncology provides new insight into the genomic landscape of rhabdomyosarcoma and suggests that treatment stratification should integrate molecular features.